Cargando…

Tissue Plasminogen Activator in Critically Ill Adults with COVID-19

Detalles Bibliográficos
Autores principales:	Douin, David J., Shaefi, Shahzad, Brenner, Samantha K., Gupta, Shruti, Park, Isabel, Wright, Franklin L., Mathews, Kusum S., Chan, Lili, Al-Samkari, Hanny, Orfanos, Sarah, Radbel, Jared, Leaf, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641829/ https://www.ncbi.nlm.nih.gov/pubmed/33872546 http://dx.doi.org/10.1513/AnnalsATS.202102-127RL

Ejemplares similares

Machine Learning Prediction of Death in Critically Ill Patients With Coronavirus Disease 2019
por: Churpek, Matthew M., et al.
Publicado: (2021)

Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
por: Orfanos, Sarah, et al.
Publicado: (2020)

Outcomes of Critically Ill Pregnant Women with COVID-19 in the United States
por: Easter, Sarah Rae, et al.
Publicado: (2021)

Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study
por: Green, Adam, et al.
Publicado: (2023)

Hospital-Level Variation in Death for Critically Ill Patients with COVID-19
por: Churpek, Matthew M., et al.
Publicado: (2021)

Echocardiographic Evidence of Cardiac Atrophy in the Critically Ill
por: Kumaresan, Abirami, et al.
Publicado: (2022)

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Prevalence of Clostridioides difficile Infection in Critically Ill Patients with Extreme Leukocytosis and Diarrhea
por: Teja, Bijan, et al.
Publicado: (2021)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic
por: Al-Samkari, Hanny
Publicado: (2023)

Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19
por: Sunderraj, Ashwin, et al.
Publicado: (2022)

Hispanic ethnicity and mortality among critically ill patients with COVID-19
por: Ricardo, Ana C., et al.
Publicado: (2022)

Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
por: Murakami, Naoka, et al.
Publicado: (2023)

Iron as an emerging therapeutic target in critically ill patients
por: Grange, Coralie, et al.
Publicado: (2023)

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
por: Kritharis, Athena, et al.
Publicado: (2018)

Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19
por: Vasquez, Charles R., et al.
Publicado: (2021)

Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice
por: Song, Fei, et al.
Publicado: (2021)

Therapeutic advances in COVID-19
por: Murakami, Naoka, et al.
Publicado: (2022)

Author Correction: Therapeutic advances in COVID-19
por: Murakami, Naoka, et al.
Publicado: (2023)

Acute kidney injury adjusted to volume status in critically ill patients: recognition of delayed diagnosis, restaging, and associated outcomes
por: Yacoub, Harout, et al.
Publicado: (2016)

Hyperoxia is associated with a greater risk for mortality in critically ill traumatic brain injury patients than in critically ill trauma patients without brain injury
por: Douin, David J, et al.
Publicado: (2023)

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19
por: Shaefi, Shahzad, et al.
Publicado: (2021)

Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features
por: Cheloff, Abraham Z., et al.
Publicado: (2020)

The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Triage and Ongoing Care for Critically Ill Patients in the Emergency Department: Results from a National Survey of Emergency Physicians
por: Mathews, Kusum S., et al.
Publicado: (2020)

Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients
por: Leaf, David E, et al.
Publicado: (2015)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
por: Cyrille, Nicole B., et al.
Publicado: (2016)

Hyperglycemia Is Associated With Increased Mortality in Critically Ill Patients With COVID-19
por: Bass*, Ilana R, et al.
Publicado: (2021)

A critical role for plasminogen in inflammation
por: Baker, Sarah K., et al.
Publicado: (2020)

Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19
por: Mazori, Alon Y., et al.
Publicado: (2021)

Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias
por: Al-Samkari, Hanny, et al.
Publicado: (2021)

MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study
por: Barrett, Christopher D., et al.
Publicado: (2022)

Association Between Hyperoxia, Supplemental Oxygen, and Mortality in Critically Injured Patients
por: Douin, David J., et al.
Publicado: (2021)

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients
por: Leiva, Orly, et al.
Publicado: (2020)

Recognition of thrombotic risk of thrombocytosis in iron deficiency
por: Al-Samkari, Hanny, et al.
Publicado: (2021)

Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19
por: Toth-Manikowski, Stephanie M., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
por: Meloche, Chelsea, et al.
Publicado: (2021)

Uric Acid and Acute Kidney Injury in the Critically Ill
por: Srivastava, Anand, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t96vck2ie8r3l8nileg07dfejd